{"database": "lobbying", "table": "lobbying_activities", "rows": [[3002213, "64adb652-31ba-467d-9f1d-8040ef8c8be0", "Q2", "MS. ERIN MOFFET", 401107015, "THE LIAISON GROUP ON BEHALF OF THE NATIONAL CANNABIS ROUNDTABLE", 2023, "second_quarter", "GOV", "As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. NCR also supported the reintroduction of the PREPARE Act (HR 2598), which directs federal agencies as to best practices and regulations upon federal legalization.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-13T10:11:07-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3002213"], "units": {}, "query_ms": 0.3278430085629225, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}